13F

Stock

Ascendis Pharma A/S

ASND · held by 4 managers

Reported value

$5.35M

Holders

4

+1 new · −1 exited

Holders’ est. mark

−$1.85M

Price effect on 3 books still in the name

Largest holder

$4.64M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC1.62M$4.64M−$2.54MAdded$2.05M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main4.63K$692.1K$686.4KCut−$5.71M
Leonteq Securities AG109$16.3K$1.41KCut−$19.6K

Who left

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.